Compounds > 4-methoxyamphetamine
Page last updated: 2024-08-23

4-methoxyamphetamine and Prostatic Neoplasms

4-methoxyamphetamine has been researched along with Prostatic Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Haapasalmi, S; Kellokumpu-Lehtinen, PI; Lehto, JT; Metsänoja, R; Piili, RP1
Fagot-Campagna, A; Gastaldi-Ménager, C; Lesuffleur, T; Rébillard, X; Tanguy-Melac, A; Tuppin, P1
Haglind, E; Steineck, G; Stranne, J; Thorsteinsdottir, TK; Valdimarsdottir, H; Wilderäng, U1
Ciechanowski, K; Kram, A; Myślak, M; Ostrowski, M; Pabisiak, K; Safranow, K; Sieńko, J; Sulikowski, T1
Emberton, M1
Epstein, JI; Isharwal, S; Miller, MC; Partin, AW; Veltri, RW1
Groopman, J; Hartzband, P1
Albertsen, PC; Barry, M; Nelson, PS; Penson, DF; Stanford, JL1

Other Studies

8 other study(ies) available for 4-methoxyamphetamine and Prostatic Neoplasms

ArticleYear
End-of-life Decision-making Differs Between a Cancer and a Dementia Patient: Influences of the Physician's Background Factors.
    Anticancer research, 2023, Volume: 43, Issue:8

    Topics: Attitude of Health Personnel; Death; Decision Making; Dementia; Humans; Male; Physicians; Prostatic Neoplasms; Surveys and Questionnaires; Terminal Care

2023
Health care utilization by men with prostate cancer during the year before their death: A 2015 population-based study.
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2019, Volume: 29, Issue:16

    Topics: Aged; Aged, 80 and over; Death; France; Humans; Male; Patient Acceptance of Health Care; Prostatic Neoplasms; Retrospective Studies; Time Factors

2019
Thinking about one's own death after prostate-cancer diagnosis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:5

    Topics: Adult; Aged; Death; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms; Surveys and Questionnaires

2018
Prostate-Specific Antigen: Nonspecific in Deceased Organ Donors.
    Transplantation proceedings, 2016, Volume: 48, Issue:5

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma; Death; Donor Selection; Europe; Humans; Italy; Male; Middle Aged; Poland; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Time Factors; Tissue Donors; Urinary Catheterization; Young Adult

2016
Is a negative prostate biopsy a risk factor for a prostate cancer related death?
    The Lancet. Oncology, 2017, Volume: 18, Issue:2

    Topics: Biopsy; Death; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors

2017
Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.
    The Prostate, 2010, Sep-01, Volume: 70, Issue:12

    Topics: Aged; Death; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; Time Factors; United States

2010
There is more to life than death.
    The New England journal of medicine, 2012, Sep-13, Volume: 367, Issue:11

    Topics: Adult; Breast Neoplasms; Death; Decision Support Techniques; Early Detection of Cancer; False Positive Reactions; Female; Humans; Male; Mammography; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Risk Assessment

2012
Determining cause of death in prostate cancer: are death certificates valid?
    Journal of the National Cancer Institute, 2001, Dec-05, Volume: 93, Issue:23

    Topics: Aged; Aged, 80 and over; Cause of Death; Death; Death Certificates; Hospitals; Humans; Male; Middle Aged; Prostatic Neoplasms

2001